FDA Inspection 1262179 — Advance Pharmaceutical Inc

Advance Pharmaceutical Inc — FEI 2434807

The FDA completed an inspection of Advance Pharmaceutical Inc on February 27, 2025 in Holtsville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Holtsville, NY (United States)

Citations

IDCFRDescription
140921 CFR 211.42(c)(4)In-Process Material Area
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
180921 CFR 211.160(a)Following/documenting laboratory controls